Home > Income Statement > MANKIND PHARMA

MANKIND PHARMA
Revenue

    Back to Income Statement
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹10,260 Cr₹874,943 Cr₹7,782 Cr₹621 Cr₹58,719 Cr

What is the latest Revenue of MANKIND PHARMA ?

The latest Revenue ratio of MANKIND PHARMA is ₹10,260 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹10,260 Cr
Mar2024₹874,943 Cr
Mar2023₹7,782 Cr
Mar2022₹621 Cr
Mar2021₹58,719 Cr

How is Revenue of MANKIND PHARMA Trending?

Years Revenue % Change
Mar2025 ₹10,260 Cr
-98.83
Mar2024 ₹874,943 Cr
11,143.81
Mar2023 ₹7,782 Cr
1,152.18
Mar2022 ₹621 Cr
-98.94
Mar2021 ₹58,719 Cr -

Compare Revenue of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹86,681.8 Cr -6.4% -3.4% -16.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,905.0 Cr -5.2% -7.6% -8.6% Stock Analytics
DIVIS LABORATORIES ₹159,357.0 Cr -5.6% -7.3% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹134,788.0 Cr -0.6% 4.8% 25% Stock Analytics
CIPLA ₹110,628.0 Cr -4.5% -9.7% -4.6% Stock Analytics
DR REDDYS LABORATORIES ₹96,441.5 Cr -2.6% -9.7% -10.5% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-6.4%

-3.4%

-16.6%

SENSEX

-2.1%

-3%

6.8%


You may also like the below Video Courses